CVC Capital Partners has announced the acquisition of MedRisk (posted on 2月 24, 2021).
Jazz Pharmaceuticals has announced the acquisition of GW Pharmaceuticals (posted on 2月 4, 2021).
Nordic Capital has announced the acquisition of Advanz Pharma (posted on 2月 1, 2021).
Eagle Pharmaceuticals’ Japanese Licensing Partner SymBio Announces Completion of Clinical Trial Enrollment for TREAKISYM® Rapid Infusion Liquid Bendamustine Formulation | Eagle Pharmaceuticals Investor Center
Press Releases | Eagle Pharmaceuticals Investor Center
Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Results | Eagle Pharmaceuticals Investor Center
Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 | Eagle Pharmaceuticals Investor Center
Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY™ (Pemetrexed for Injection) | Eagle Pharmaceuticals Investor Center
Eagle Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
Eagle Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube
Eagle Pharmaceuticals 拥有 2,045 家竞争者,其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Roche (瑞士)。